The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia.


It is not known whether H(2)S can promote angiogenesis with improvement of regional blood flow in ischemic organs. Sodium hydrosulfide (NaHS, a H(2)S donor) was administered once a day for 4 w following femoral artery ligation. Collateral vessel growth, capillary density, regional tissue blood flow, the expression of endothelial growth factor (VEGF), VEGF receptor 2 (VEGFR2) and Akt were examined during or at the end of the treatment period. NaHS treatment significantly increased collateral vessel growth, capillary density, and regional tissue blood flow in ischemic hind limb muscles compared with the controls. These effects were associated with an increase in VEGF expression in the skeletal muscles and VEGFR2 phosphorylation in the neighboring vascular endothelial cells, suggesting a role of VEGF in mediating the NaHS effects in a cell-cell interaction pattern. Moreover, NaHS treatment also resulted in an increase in Akt phosphorylation in ischemic hind limb muscles. In conclusion, our observations with NaHS strongly suggest that H(2)S is a proangiogenic factor in chronic ischemia. The proangiogenic effect of NaHS may be mediated by interaction between the upregulated VEGF in the skeletal muscle cells and the VEGFR2 as well as its downstream signaling element Akt in the vascular endothelial cells.

DOI: 10.1089/ars.2009.2945
Citations per Year

480 Citations

Semantic Scholar estimates that this publication has 480 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Wang2010TheHS, title={The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia.}, author={Ming-Jie Wang and Wen-Jie Cai and Na Li and Ying-Jiong Ding and Ying Chen and Yi-Chun Zhu}, journal={Antioxidants & redox signaling}, year={2010}, volume={12 9}, pages={1065-77} }